Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06296901 · ClinicalTrials.gov registry record · NA
To Wipe or Not To Wipe?: That Is The Question
A NA study of Urinary Tract Infections, sponsored by Joanna A. Orzel.
- Active
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT06296901: Active NA study of Urinary Tract Infections, sponsored by Joanna A. Orzel.
NCT06296901 is a NA study of Urinary Tract Infections that is active but no longer recruiting, run by Joanna A. Orzel. The registered enrollment target is 600 participants, above the 441-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06296901, a NA study of Urinary Tract Infections, is active but no longer recruiting, sponsored by Joanna A. Orzel.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this randomized control trial is to characterize whether a mid-stream clean catch sample using a cleansing wipe in the setting of symptomatic UTI in a female patient is associated with a lower rate of contamination. We hypothesize that using a perineal cleansing wipe at the time of a midstream urine sample will decrease rates of contamination for female patients with a symptomatic UTI.
Primary Outcome
rate of contamination of midstream clean catch urine samples
Conditions Studied
Interventions
- OTHER Perineal Wipe
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2027-10 |
| Phase | NA |
What the registry record for NCT06296901 still lists
NCT06296901 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 441-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (36% higher).
The record links to 1 condition, with Urinary Tract Infections appearing as the primary indexed condition, and to 1 intervention - of which Perineal Wipe is the first listed.
NCT06296901 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT06296901 about?
NCT06296901 is a clinical study titled "To Wipe or Not To Wipe?: That Is The Question". The primary aim of this randomized control trial is to characterize whether a mid-stream clean catch sample using a cleansing wipe in the setting of symptomatic UTI in a female patient is associated with a lower rate of contamination. We hypothesize that using a perineal cleansing wipe at the time o...
What is the current status of trial NCT06296901?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-04-01. Estimated completion is 2027-10.
What conditions does trial NCT06296901 study?
This clinical trial studies the following conditions: Urinary Tract Infections.
What interventions are being tested in trial NCT06296901?
The interventions under investigation include: Perineal Wipe (OTHER).
Who is sponsoring clinical trial NCT06296901?
This trial is sponsored by Joanna A. Orzel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06296901 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06296901's enrollment target sits among peer trials
600 8th of 34 higher than 27 of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Double Voiding and Post-transplant UTI
RECRUITING · NA
-
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
RECRUITING · NA
-
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI